Bioworld Financial Watch articles from September 2005

Bioworld Financial Watch archives from September 2005

GSK, MedImmune license pact draws notice to staph wars.
September 5, 2005... The anti-staph field got potentially more complicated last week when a would-be challenge to research leader Inhibitex Inc. appeared on the horizon. MedImmune Inc. and pharmaceutical giant GlaxoSmithKline plc entered a licensing deal with...

10 biggest U.S. gainers for the week.
September 5, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Tercica 38.93 Biopure 35.88 Transgenomic 31.25 Icoria 25.00 Osteotech 24.44 Viragen 22.58 Chiron 21.25 InSite Vision...

10 biggest U.S. losers for the week.
September 5, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) MacroChem -71.90 Insmed -36.36 Carrington -24.18 Tapestry Pharma -20.41 Access Pharma -18.67 Siga Technol -16.67 Immunicon -15.20...

Collaborations between biotechnology companies and government/nonprofit institutions: May 20-Aug. 31, 2005.
September 5, 2005... Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: May 20-Aug. 31, 2005 Company * University/ Type Of (Country; Symbol) Nonprofit (@) Agreement Ablynx NV * ...

BioWorld stock report for public biotechnology companies.
September 5, 2005... BioWorld Stock Report For Public Biotechnology Companies %Change Company Symbol Close Close Vol 8/26 9/2 WK...

Novartis tapping Alnylam; Sirna 'sticks to strategy'.(RNAi Patent 'Debate' Due Later?)
September 12, 2005... "We think, unquestionably, we're the leaders," said Van Miles, senior vice president of business development for Alnylam Pharmaceuticals Inc., talking last week about RNA interference. Howard Robin, CEO of Sirna Therapeutics Inc., saw the...

10 biggest U.S. gainers for the week.
September 12, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Deltagen 90.91 Alnylam 42.03 Hana Bio 33.43 Access Pharma 21.31 Insmed 19.78 CombiMatrix 18.75 Trinity Bio ...

10 biggest U.S. losers for the week.
September 12, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Albany Molecular -26.65 Questcor Pharma -16.67 Biopure -15.73 Solexa -14.57 Avax Technol -14.29 Biotime -13.73 Viragen ...

Public financing of biotechnology: August 2005.
September 12, 2005... I. COMMENCED TRADING IN AUGUST Company Date Date Shares/ Price Shares (Symbol) (#) Filed Comm. Units (M) Out (M)...

Other financings of public biotechnology companies: August 2005.
September 12, 2005... Other Financings Of Public Biotechnology Companies: August 2005 TOTAL: $764.71M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: August 2005.
September 12, 2005... I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $435.39M Company Location Date Amt. (M) Alba Baltimore 8/23/05 $30 Therapeutics Corp. Alder Bio- Seattle ...

BioWorld stock report for public biotechnology companies.
September 12, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close WK YTD Vol 9/2 9/9 ...

Magic bullet still missing for lung cancer sufferers.
September 19, 2005... "NSCLC" might sound like a sports league to some, but the acronym has a much more dire meaning to physicians and their patients, who battle a disease yet to meet its match in the laboratory despite the best efforts of biotechnology firms. ...

10 biggest U.S. gainers for the week.
September 19, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Advancis 126.88 Deltagen 33.33 Metabasis 29.25 Trimeris 21.98 DepoMed 20.43 Vical 19.91 Stratagene 16.36...

10 biggest U.S. losers for the week.
September 19, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Biopure -29.33 Ergo Science -25.88 GTC Biothera -25.00 Genaera -19.85 MacroChem -16.67 Miravant -16.28 Transgene -15.62 Epix...

Clinical trials update: August 2005.
September 19, 2005... Clinical Trials Update: August 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE BioCryst BCX-4208 Second-generation, Pharmaceuticals ...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: August 2005.
September 19, 2005... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: August 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Abbott Humira Adalimumab;...

FDA submission, approvals and other actions: August 2005.
September 19, 2005... FDA Submission, Approvals And Other Actions: August 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Genentech Rituxan Rituximab; antibody that Inc. (NYSE:DNA) ...

BioWorld stock report for public biotechnology companies.
September 19, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close WK YTD Vol 9/9 9/16 ...

Hana sitting pretty with NSCLC drug--and more.
September 26, 2005... Last week's cover story examined the scourge of non-small-cell lung cancer--the dismal prognosis for patients and the limited options for treatment. But "limited options" isn't really the right phrase, since the problem is not the number of...

10 biggest U.S. gainers for the week.
September 26, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) North Amer Scien 47.06 Access Pharma 30.67 Icoria 36.84 GTC Biothera 29.17 VioQuest 26.32 Genta ...

10 biggest U.S. losers for the week.
September 26, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Advancis -20.85 GenVec -20.62 QLT PhotoTher -18.02 Viragen -17.91 Gene Logic -17.50 ViaCell -16.46 Anadys ...

Grants, contracts and awards to biotech companies: May 26-Sept. 22, 2005.
September 26, 2005... Grants, Contracts And Awards To Biotech Companies: May 26-Sept. 22, 2005 Company * Funding Amount (Country; Symbol) Institution (M) Aastrom National Institute ...

BioWorld stock report for public biotechnology companies.
September 26, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 9/16 9/23 ...